Boehringer Ingelheim Pharmaceuticals, Inc. Recalls

1 recall on record in the United States

drugs: 1
drugs Class II
2026-07-08

Boehringer Ingelheim Pharmaceuticals, Inc. recalls Synjardy XR Tablets (empagliflozin and metformin hydrochlori

CGMP Deviations: An incorrect detergent was used and the required swab sampling was not performed on a production hopper that had previously been used for a different product.

View recall details →